Aripiprazole reverses Paliperidoneinduced Hyperprolactinemia

Authors

  • Nieves Basterreche Short Stay Unit Hospital de Zamudio. Red de Salud Mental de Bizkaia Psychiatry Department Facultad de Medicina Universidad del Pais Vasco
  • Mercedes Zumárraga Neurochemical Research Department Hospital de Zamudio Red de Salud Mental de Bizkaia
  • Aurora Arrue Neurochemical Research Department Hospital de Zamudio Red de Salud Mental de Bizkaia
  • Olga Olivas Short Stay Unit Hospital de Zamudio. Red de Salud Mental de Bizkaia
  • Wendy Dávila Avances Médicos SA

Keywords:

Hyperprolactinemia, Paliperidone, Aripiprazole

Abstract

Hyperprolactinemia is a common side effect of antipsychotic treatments. Existing alternatives to resolve this problem include decreasing the antipsychotic dose or switching to a different antipsychotic agent. Nevertheless, said modifications can sometimes lead to decompensation of the patient. We report a clinical case of a female patient in whom the combined treatment of 5 mg/day of aripiprazole (5 mg/day) reversed paliperidoneinduced hyperprolactinemia within four weeks.

Downloads

Published

2012-09-01

How to Cite

Basterreche, Nieves, et al. “Aripiprazole Reverses Paliperidoneinduced Hyperprolactinemia”. Actas Españolas De Psiquiatría, vol. 40, no. 5, Sept. 2012, pp. 290-2, https://actaspsiquiatria.es/index.php/actas/article/view/829.

Issue

Vol. 40 No. 5 (2012)

Section

Clinical Note